He focuses on commercializing medical innovations and vaccines R&D projects including Influenza vaccine, dengue fever vaccine and therapeutic medicines for Amyotrophic Lateral Sclerosis (ALS/Lou Gehrig’s Disease).

Mr. Makarenko participated in various scientific research and projects including EpiVacDengue Peptide vaccine, Multi-subunit BCG booster TB vaccine, Chondroitin-6 Sulfate (CS-A), Glucosamine and amino acids extracted from sturgeons scientific survey and feasibility study where he acted both as investor and project manager.

Based in Singapore & working on 4 continents (Asia, Africa, Latin America & Europe), Alexey has successful track record of securing multi-million dollar contracts, leading cross-border due-diligence teams, knowledge of investment policies & international law requirements, investment attraction & master development. With recent focus on ASEAN countries, Alexey participated in various projects such as New Clark City Ph1 in the Philippines, Eastern Economic Corridor Industrial development in Thailand, multiple developments in Indonesia & Vietnam.